Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Breast (Edinburgh, Scotland)
|
July 6, 2024
Questionnaire survey and analysis of drug clinical research implementation capabilities of breast cancer treatment departments in Chinese hospitals
Bo Lan, Xuenan Peng, Fei Ma
Frontiers in Oncology
|
February 2, 2023
Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma
Xuenan Peng, Caifeng Gong, Wen Zhang, et al.
Wei Sheng Yan Jiu = Journal of Hygiene Research
|
October 12, 2019
[Average blood glucose construction: a multi-level Bayes model approach and application]
Jinzhuo Ge, Xuenan Peng, Chunhua Zhao, et al.
International Journal of Hypertension
|
May 7, 2020
Longitudinal Average Glucose Levels and Variance and Risk of Stroke: A Chinese Cohort Study
Xuenan Peng, Jinzhuo Ge, Congju Wang, et al.
The Journal of Obstetrics and Gynaecology Research
|
April 13, 2019
Characteristics of midluteal phase uterine artery hemodynamics in patients with recurrent pregnancy loss
Wen Yang, Ze Wu, Ming Yu, et al.
BMC Medicine
|
February 26, 2025
Exploration of the clonal evolution and construction of the tumor clonal evolution rate as a prognostic indicator in metastatic breast cancer
Dan Lv, Bo Lan, Qihan Guo, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
June 22, 2019
Coagulation parameters predictive of polycystic ovary syndrome
Qian Sun, Yan Yang, Xuenan Peng, et al.
Frontiers in Immunology
|
January 2, 2026
The long pentraxin 3: the invisible loom weaving the warp and weft of tumor destiny
Tianyi Liu, Manyu Li, Yuxi Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2022
Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients
Wen Zhang, Caifeng Gong, Xuenan Peng, et al.
Therapeutic Advances in Medical Oncology
|
January 5, 2026
Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study
Xuenan Peng, Ruixia Song, Ying Fan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Breast (Edinburgh, Scotland)
|
July 6, 2024
Questionnaire survey and analysis of drug clinical research implementation capabilities of breast cancer treatment departments in Chinese hospitals
Bo Lan, Xuenan Peng, Fei Ma
Frontiers in Oncology
|
February 2, 2023
Advanced development of biomarkers for immunotherapy in hepatocellular carcinoma
Xuenan Peng, Caifeng Gong, Wen Zhang, et al.
Wei Sheng Yan Jiu = Journal of Hygiene Research
|
October 12, 2019
[Average blood glucose construction: a multi-level Bayes model approach and application]
Jinzhuo Ge, Xuenan Peng, Chunhua Zhao, et al.
International Journal of Hypertension
|
May 7, 2020
Longitudinal Average Glucose Levels and Variance and Risk of Stroke: A Chinese Cohort Study
Xuenan Peng, Jinzhuo Ge, Congju Wang, et al.
The Journal of Obstetrics and Gynaecology Research
|
April 13, 2019
Characteristics of midluteal phase uterine artery hemodynamics in patients with recurrent pregnancy loss
Wen Yang, Ze Wu, Ming Yu, et al.
BMC Medicine
|
February 26, 2025
Exploration of the clonal evolution and construction of the tumor clonal evolution rate as a prognostic indicator in metastatic breast cancer
Dan Lv, Bo Lan, Qihan Guo, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
June 22, 2019
Coagulation parameters predictive of polycystic ovary syndrome
Qian Sun, Yan Yang, Xuenan Peng, et al.
Frontiers in Immunology
|
January 2, 2026
The long pentraxin 3: the invisible loom weaving the warp and weft of tumor destiny
Tianyi Liu, Manyu Li, Yuxi Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2022
Serum Concentration of CD137 and Tumor Infiltration by M1 Macrophages Predict the Response to Sintilimab plus Bevacizumab Biosimilar in Advanced Hepatocellular Carcinoma Patients
Wen Zhang, Caifeng Gong, Xuenan Peng, et al.
Therapeutic Advances in Medical Oncology
|
January 5, 2026
Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study
Xuenan Peng, Ruixia Song, Ying Fan, et al.
Page
of 2